TrialThe Journal of experimental medicine2021

A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment.

Alessia Balestrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.